Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia

Completed · Phase 2 · Has a placebo group

Conditions studied: Alzheimer's Disease, Dementia With Lewy Bodies, Parkinson's Disease Dementia

In brief

This study seeks to evaluate the effect of intepirdine (RVT-101) on gait and balance in patients with Alzheimer's Disease, Dementia with Lewy Bodies or Parkinson's Disease Dementia.

Key facts

Study ID

NCT02910102

Run by

Axovant Sciences Ltd.

People needed

38

Starts

2016-10-01

Expected to finish

2017-11-01

Last updated by the study team

2020-04-28

Who can join

Age: 50 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

Where it is running

• US101 — Phoenix, Arizona, United States
• US118 — Simi Valley, California, United States
• US117 — Temecula, California, United States
• US115 — Boca Raton, Florida, United States
• US109 — Hallandale, Florida, United States
• US116 — Miami, Florida, United States
• US108 — Pensacola, Florida, United States
• US106 — Columbus, Georgia, United States
• US107 — Indianapolis, Indiana, United States
• US102 — Ann Arbor, Michigan, United States
• US111 — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.